Stay updated on Pembrolizumab Effects in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Effects in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed as part of the site's versioning. The study details page content and layout appear unchanged.SummaryDifference0.1%

- Check8 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe changes are limited to the site's footer: a new Revision: v3.4.2 tag and updated/removed generic operating-status notices. There is no impact on the study details, eligibility criteria, or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check43 days agoChange DetectedA site-wide notice about a lapse in government funding has been added and the page revision updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check50 days agoChange DetectedShow glossary has been added, and a new 'Last Update Submitted that Met QC Criteria' field is displayed. The old 'Last Update Submitted that met QC Criteria' label, casing of 'No FEAR Act data', and the page revision have been updated to v3.4.0.SummaryDifference0.2%

- Check64 days agoChange DetectedFooter shows a minor version update: Revision v3.3.4 added and v3.3.3 removed; no changes to study details, eligibility, or endpoints are apparent.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Effects in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.